TAG:
blood brothers
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
Quest Diagnostics and LabCorp Face an Evolving Marketplace
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
TWO OF THE THREE BLOOD BROTHERS reported continued improvement in their financial condition as second quarter earnings reports were made public. This news, however, was overshadowed by speculation about the failure of Quest Diagnostics Incorporated to consummate its purchase of …
LabCorp Making Steady Progress On Path Back to Financial Health
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
MOST OF THE LAB INDUSTRY is watching the impending acquisition by Quest Diagnostics Incorporated of SmithKline Beecham Clinical Laboratories (SBCL). This big news overshadows the steady gains made at Laboratory Corporation of America in its efforts …
Client Service and Sales Fuel Fast Growth at AML
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CEO SUMMARY: Here’s proof positive that effective management can make a positive difference in the financial performance of clinical labs. Upon taking title to American Medical Laboratories in the spring of 1997, its new owners used an emphasis on “customer-first” service and aggres…
Unilab, DIANON Systems, UroCor Report 1998 Financial Results
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
OPTIMISM REIGNS at California-based Unilab Corporation. Revenues are up, operating profits are increasing, and company officials are now talking about growth plans. For 1998, Unilab generated revenues of $217.4 million, compared to $214.0 million in 1997. …
Three Blood Brothers Release Year-End Financial Performance
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
FINANCIAL REPORTS RELEASED by the three national laboratories for the fiscal year 1998 reveal a definite improvement in their financial performance and cash flow. One sign of this improvement is the fact that none of the three blood brothers disclosed any huge write-downs similar to those experience…
Good Market Analysis Leads to Accurate Predictions
By R. Lewis Dark | From the Volume VI No. 3 – February 22, 1999 Issue
HOW MANY OF YOU REMEMBER WHEN, JUST A FEW YEARS AGO, it was MetPath/Corning Clinical Laboratories (CCL) which was on the financial ropes? At that time, SmithKline Beecham, PLC was expected to be the likely purchaser of CCL. The date was January 31, 1996. The Wall Street Journal…
DARK REPORT Picks 1998’s Ten Biggest Lab Stories
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY: Our story picks for 1998 demonstrate a broad range of subjects. Each affects laboratories and pathology practices in significant ways and should be used to trigger appropriate management strategies. Two essential themes among this year’s ten biggest lab stories: continued d…
Total Laboratory Automation: It’s “ DOA” In Today’s Market
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY: Since 1994, thoughtful lab executives have wrestled with the concept of total automation for their laboratory. Despite concerted marketing efforts by some of the world’s most successful diagnostics manufacturers, only a handful of total laboratory automation (TLA) sites are…
Improved 3rd Quarter Performance Posted By National Laboratories
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
Third quarter financial performance at all three national laboratories improved over the same period of 1997. It is an important sign that the three companies are stabilizing their finances. All three national laboratories continue to emphasize cost-cutting as a major corporate priority. That is to …
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized